Customized research for PBYI vs. TCRR!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for PBYI vs. TCRR.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Puma Biotechnology, Inc. vs. TCR2 Therapeutics Inc.

Industry Match! Industry of Both PBYI and TCRR:

Health Care/Life Sciences

PBYI
Data Last Updated: 3 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 408.214M


P/E: N/A

P/S: 1.5

Q P/B: 17.45

Y Rev: 272.26M

Q Rev: 70.58M

Beta: 1.23

PBYI Share Stats

Outstanding Shares

39.68M

Float Shares

32.87M

Percent of Float Short

22.66%

PBYI Insider Stats

Percent Outstanding Insider Ownership

12.48%

Percent Outstanding Institution Ownership

50.36%

PBYI Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

PBYI in Pulse Portal

Stream of Posts

PBYI Symbol Page

Share PBYI Insights

Express Sentiment

'Buy' or 'Sell' PBYI

PBYI Profile

CEO

Mr. Alan H. Auerbach

Exchange

Nasdaq

Employees

269.00

About

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial...

PBYI Financials

Annual Financials

Income Statement

Revenue

272.26M

Net Income

(75.6M)

Cash Flow Statement

Change in Cash / Investments

(39.53M)

Balance Sheet

Cash / Investments

120.49M

Short Term Debt

2.62M

Long Term Debt

94.96M

Total Current Assets

166.14M

Total Current Liabilities

90.84M

Total Assets

234.91M

Total Liabilities

217.44M

Stockholder Equity

17.46M

Quarterly Financials

Income Statement

Q Revenue

70.58M

Q Net Income

3.4M

Cash Flow Statement

Q Change in Cash / Investments

7.01M

Balance Sheet

Q Cash / Investments

116.12M

Q Short Term Debt

2.85M

Q Long Term Debt

96.57M

Q Total Current Assets

159.03M

Q Total Current Liabilities

94.53M

Q Total Assets

263.81M

Q Total Liabilities

240.41M

Q Stockholder Equity

23.4M

PBYI Charts

10-Year Chart

PBYI 10-Year Chart

5-Year Chart

PBYI 5-Year Chart

1-Year Chart

PBYI 1-Year Chart

6-Month Chart

PBYI 6-Month Chart

3-Month Chart

PBYI 3-Month Chart

1-Month Chart

PBYI 1-Month Chart

1-Day Chart

PBYI 1-Day Chart

TCRR
Data Last Updated: More than a wk ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 606.527M


P/E: N/A

P/S: N/A

Q P/B: 4.55

Y Rev: -

Q Rev: -

Beta: N/A

TCRR Share Stats

Outstanding Shares

33.34M

Float Shares

27.47M

Percent of Float Short

5.23%

TCRR Insider Stats

Percent Outstanding Insider Ownership

0.25%

Percent Outstanding Institution Ownership

14.78%

TCRR Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

TCRR in Pulse Portal

Stream of Posts

TCRR Symbol Page

Share TCRR Insights

Express Sentiment

'Buy' or 'Sell' TCRR

TCRR Profile

CEO

Dr. Garry E. Menzel

Exchange

Nasdaq

Employees

83.00

About

TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering t-cells for cancer therapy. The firm offers cancer therapy, t-cell biology, immunology and molecular biology. It also engages in the research and collaboration with...

TCRR Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(47.6M)

Cash Flow Statement

Change in Cash / Investments

17.75M

Balance Sheet

Cash / Investments

158.12M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

163.19M

Total Current Liabilities

7.53M

Total Assets

168.53M

Total Liabilities

8.08M

Stockholder Equity

160.45M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(16.25M)

Cash Flow Statement

Q Change in Cash / Investments

18.6M

Balance Sheet

Q Cash / Investments

124.81M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

133.78M

Q Total Current Liabilities

6.36M

Q Total Assets

140.38M

Q Total Liabilities

6.97M

Q Stockholder Equity

133.41M

TCRR Charts

10-Year Chart

TCRR 10-Year Chart

5-Year Chart

TCRR 5-Year Chart

1-Year Chart

TCRR 1-Year Chart

6-Month Chart

TCRR 6-Month Chart

3-Month Chart

TCRR 3-Month Chart

1-Month Chart

TCRR 1-Month Chart

1-Day Chart

TCRR 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon